Pelthos Therapeutics Inc.
PTHS
$26.90
$0.602.28%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 52.74% | -33.41% | -370.83% | -75.25% | -2.18% |
| Total Depreciation and Amortization | 29.01% | 6.57% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -100.00% | -99.94% | 75.21% | 23.68% |
| Total Other Non-Cash Items | -112.05% | 278.02% | 1,077.92% | -14.92% | -8.30% |
| Change in Net Operating Assets | 42.26% | 16.21% | -307.67% | 220.58% | 16.31% |
| Cash from Operations | -109.95% | 59.03% | -3,312.82% | 29.26% | 5.67% |
| Capital Expenditure | -95.96% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -386.06% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 97.57% | -389.64% | -- | -- | -- |
| Total Debt Issued | 63.91% | 26,220.59% | -81.87% | 50.00% | 262.34% |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | -- | 42.35% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 52.74% | -32.49% | 7,017.87% | 50.00% | 447.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 276.74% | -73.44% | 19,786.96% | 81.13% | 48.52% |